Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10201/20651
Twittear
Título: | Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention |
Fecha de publicación: | 2001 |
Editorial: | Murcia : F. Hernández |
ISSN: | 0213-3911 |
Materias relacionadas: | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología |
Palabras clave: | Hepatocyte growth factor cMET protooncogene |
Resumen: | Hepatocyte growth factor (HGF), otherwise known as scatter factor (SF), has been demonstrated over the past decade to elicit a number of functions that may be tumorigenic, and enhance the invasive/metastatic nature of cancer cells. Clinical studies have also demonstrated that HGFJSF, together with its receptor, cMET, is closely related to the disease progression and prognosis of patients with cancer. The past few years have seen the identification of numerous inhibitors and antagonists to the action of HGFISF. These factors have demonstrated a possible role in minimising the action of HGFISF on cancer cells, and may be of therapeutic value in the future. This article overviews the activators, inhibitors, and antagonists to HGFISF and discusses the possible implications in cancer therapy. |
Autor/es principal/es: | Parr, C. Jiang, W.G. |
Forma parte de: | Histology and histopathology |
URI: | http://hdl.handle.net/10201/20651 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 18 |
Derechos: | info:eu-repo/semantics/openAccess |
Aparece en las colecciones: | Vol.16, nº 1 (2001) |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Hepatocyte growth factor activators inhibitors and antagonists and their implication in cancer intervention.pdf | 11,72 MB | Adobe PDF | Visualizar/Abrir |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.